Together with the observed IL-2 and TNF levels, these findings indicate a maintained multifunctional immune capacity during COVID-19 in comparison to patients with septic bacterial pneumonia and bacterial sepsis in the early phase of the ICU stay, and suggest different impacts of these two disease patterns on immunity. The gene discussed is IL2; the disease is COVID-19.